Literature DB >> 31287498

The ESMO clinical practise guidelines for early breast cancer: diagnosis, treatment and follow-up: on the winding road to personalized medicine.

S Loi1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31287498     DOI: 10.1093/annonc/mdz201

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review.

Authors:  Anastasios Kyriazoglou; Maria Kaparelou; Georgios Goumas; Michael Liontos; Roubini Zakopoulou; Eleni Zografos; Anna Zygogianni; Meletios Athanasios Dimopoulos; Flora Zagouri
Journal:  Breast Care (Basel)       Date:  2021-03-29       Impact factor: 2.860

2.  Prosigna test in breast cancer: real-life experience.

Authors:  D Hequet; G Harrissart; D Krief; L Maumy; F Lerebours; E Menet; C Callens; R Rouzier
Journal:  Breast Cancer Res Treat       Date:  2021-04-15       Impact factor: 4.872

Review 3.  Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications.

Authors:  Maria Vittoria Dieci; Federica Miglietta; Valentina Guarneri
Journal:  Cells       Date:  2021-01-23       Impact factor: 6.600

4.  «Salivaomics» of Different Molecular Biological Subtypes of Breast Cancer.

Authors:  Lyudmila V Bel'skaya; Elena A Sarf
Journal:  Curr Issues Mol Biol       Date:  2022-07-05       Impact factor: 2.976

Review 5.  Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine.

Authors:  Françoise Derouane; Cédric van Marcke; Martine Berlière; Amandine Gerday; Latifa Fellah; Isabelle Leconte; Mieke R Van Bockstal; Christine Galant; Cyril Corbet; Francois P Duhoux
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.